Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
With
Pfizer
Age
12–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects with chronic stable disease with any type of functioning CVC in the upper or lower venous system (e.g., jugular, subclavian; femoral vein) that is anticipated to remain in the subject for the treatment portion of the study.
\> 12 to \<18 years of age
You may not be if
Current or recent (within 3 months of study drug administration) gastrointestinal disease or gastrointestinal surgery that, in the opinion of the investigator and the BMS Medical Monitor, could impact the absorption of the study drug
Active bleeding or high risk of bleeding
Clareo Health | Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
